- Research works
- 59 ▲ 20% vs 2018-21
- Citations
- 2.9k 49.0 per fractional work
- Top-10% rate
- 9.5% all institutions 10.0%
- Open access
- 44% world 40%
- International
- 25% world 18%
Not ranked overall: Exosome Diagnostics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Exosome Diagnostics (United States) work in?
In all years, 47% of research at Exosome Diagnostics (United States) is in Life Sciences, 46% in Health Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (45%), Engineering (2%). It does 2.6× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 15 fields, with their numbers
- Life Sciences2847.1%
- Health Sciences2846.5%
- Medicine2746.2%
- Health Professions00.2%
- Dentistry00.1%
- Physical Sciences35.0%
- Engineering12.3%
- Chemistry11.7%
- Environmental Science00.7%
- Earth and Planetary Sciences00.2%
- Materials Science00.1%
- Social Sciences11.4%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.8×. Every wedge is a field page.
All 10 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology8.78×7 works
- Medicine2.32×7 works
- Immunology and Microbiology1.81×0 works
- Economics, Econometrics and Finance0.53×0 works
- Neuroscience0.47×0 works
- Health Professions0.22×0 works
- Environmental Science0.15×0 works
- Engineering0.11×0 works
- Social Sciences0.11×0 works
- Agricultural and Biological Sciences0.10×0 works
Who are the top researchers at Exosome Diagnostics (United States)?
Ranked on the quality score, Johan Skog, Mikkel Noerholm and Vasisht R. Tadigotla lead among researchers whose main affiliation is Exosome Diagnostics (United States).
- 1
Johan Skog
United States · #46,336 worldwide 24k citations · 190 works
- 2
Mikkel Noerholm
United States · #219,647 worldwide 4.8k citations · 87 works
- 3
Vasisht R. Tadigotla
United States · #298,074 worldwide 4.9k citations · 55 works
- 4
Daniel Enderle
United States · #788,574 worldwide 2.6k citations · 42 works
- 5
Stefan Bentink
United States · #953,271 worldwide 3.6k citations · 57 works
- 6
James D. Hurley
United States · #998,305 worldwide 1.9k citations · 25 works
- 7
Susan K. Belzer
United States · #1,031,177 worldwide 1.5k citations · 18 works
- 8
Sudipto K. Chakrabortty
United States · #1,274,994 worldwide 9.8k citations · 28 works
- 9
Kay Brinkmann
United States · #1,579,953 worldwide 972 citations · 34 works
- 10
Vince O’Neill
United States · #1,608,193 worldwide 1k citations · 25 works
Which keywords describe research at Exosome Diagnostics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Biomarkers, Biogenesis, Exosomes, Extracellular Vesicles, Prostate Cancer, Targeted Therapy and Clinical Guidelines.
- High-Throughput Analysis
- MicroRNA
- Inflammatory Bowel Disease
- Clinical Practice Guidelines
- Regulation
- Fc Receptors
- Metastatic Prostate Cancer
- Treatment Guidelines
- EGFR Mutations
- Genetic Mutations
- RNA Regulation
- Hormone Therapy
- Mutational Signatures
- Epidemiology
- Genomic Profiling
- Radiation Therapy
- Clinical Guidelines
- Prostate Cancer
- Exosomes
- Biomarkers
- Cancer
- Biogenesis
- Extracellular Vesicles
- Targeted Therapy
- Clinical Trials
- Screening
- Immunotherapy
- Cancer Genomics
- Glycosylation
- Long Noncoding RNAs
- Gene Expression
- ALK Inhibitors
- Therapeutics
- Androgen Receptor
- Metastasis
- Prognostic Factors
- Therapeutic Antibodies
- Crohn's Disease
- Mass Spectrometry
- Targeting
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer17▲ 20×11 topics
- Biomarkers15▲ 40×5 topics
- Biogenesis12▲ 176×3 topics
- Exosomes10▲ 619×1 topic
- Extracellular Vesicles10▲ 619×1 topic
- Prostate Cancer8▲ 87×3 topics
- Targeted Therapy7▲ 53×4 topics
- Clinical Guidelines6▲ 31×2 topics
- Clinical Trials6▲ 15×5 topics
- Radiation Therapy6▲ 64×1 topic
- Screening6▲ 99×1 topic
- Genomic Profiling5▲ 79×2 topics
- Immunotherapy5▲ 12×10 topics
- Epidemiology4▲ 1.72×11 topics
- Cancer Genomics4▲ 107×1 topic
- Mutational Signatures4▲ 107×1 topic
- Glycosylation3▲ 26×3 topics
- Hormone Therapy3▲ 50×3 topics
- Long Noncoding RNAs3▲ 81×1 topic
- RNA Regulation3▲ 45×1 topic
- Gene Expression3▲ 8.0×6 topics
- Genetic Mutations3▲ 9.5×7 topics
- ALK Inhibitors2▲ 75×1 topic
- EGFR Mutations2▲ 75×1 topic
- Therapeutics2▲ 30×2 topics
- Treatment Guidelines2▲ 20×2 topics
- Androgen Receptor2▲ 40×1 topic
- Metastatic Prostate Cancer2▲ 82×1 topic
- Metastasis2▲ 11×2 topics
- Fc Receptors2▲ 31×1 topic
- Prognostic Factors2▲ 7.1×5 topics
- Regulation2▲ 5.3×2 topics
- Therapeutic Antibodies2▲ 24×1 topic
- Clinical Practice Guidelines2▲ 5.1×5 topics
- Crohn's Disease2▲ 32×2 topics
- Inflammatory Bowel Disease1▲ 23×2 topics
- Mass Spectrometry1▲ 11×3 topics
- MicroRNA1▲ 22×1 topic
- Targeting1▲ 38×1 topic
- High-Throughput Analysis1▲ 46×1 topic
Which research topics does Exosome Diagnostics (United States) publish most on?
By volume in 2022-now: Extracellular vesicles in disease, Prostate Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics and Prostate Cancer Treatment and Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Extracellular vesicles in disease Molecular Biology 3 works
- 2 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 3 Cancer Genomics and Diagnostics Cancer Research 1 works
- 4 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 5 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 0 works
- 6 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 7 Cancer-related molecular mechanisms research Cancer Research 0 works
- 8 RNA Interference and Gene Delivery Molecular Biology 0 works
- 9 Molecular Biology Techniques and Applications Molecular Biology 0 works
- 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Exosome Diagnostics (United States)'s research output changed?
Output in 2022-2025 was 20% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Exosome Diagnostics (United States) as a percentage of every work published that year, 0.000083% in 2024.
Fractional works of Exosome Diagnostics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Waltham
- Brandeis University
- Thermo Fisher Scientific (United States)
- Bentley University
- PerkinElmer (United States)
- Education Development Center
- Foster-Miller (United States)
- Boston Engineering (United States)
- ImmunoGen (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Exosome Diagnostics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.